Anti-infectives – The patient is a 20-year-old man who presents to the clinic today for a follow-up with the pulmonologist after being diagnosed with tuberculosis (TB) of the lungs as a result of infection with Mycobacterium tuberculosis 3 weeks ago
Anti-infectives – Patient 1
Patient Data
History and Physical
The patient is a 20-year-old man who presents to the clinic today for a follow-up with the pulmonologist after being diagnosed with tuberculosis (TB) of the lungs as a result of infection with
Mycobacterium tuberculosis
3 weeks ago. A positive purified protein derivative (PPD) resulted in a chest x-ray, which revealed active TB. After 2 weeks in the hospital, the patient returned home, and directly observed therapy (DOT) is being delivered by the public health nurse daily. Patient’s weight is 160 lb. (72.73 kg).
The DOT LPN collaborates with the organization RN to prepare a care plan for the patient.
Nurses’ Notes
Directly Observed Therapy (DOT) Notes
Day 1
: Medications administered. Patient reports no side effects from the medication. Patient reports slight cough persists.
Day 2
: Medication administered. No reports of side effects.
Day 3
: Medication administered. No reports of side effects. Patient shares frustration with the need to take so many medications daily. Patient’s frustrations acknowledged.
Day 4
Medication administered. No reports of side effects. Patient reports feeling much better. Cough has resolved. Appetite returned.
Day 5
: Medication administered. No reports of side effects. Patient shares that he cried today, and his tears were red. Education provided.
Day 6
: Medication administered. No report of side effects. Patient expresses desire to drink alcohol. Shares that he drank 1-3 beers every night before diagnosis. Education provided.
Laboratory Results
Test
Value
Reference Range
Bilirubin
6.2
5.1 to 17 μmol/L
Alkaline phosphatase
60
30 to 120 U/L
Aspartate transaminase
38
0 to 35 U/L
Alanine transaminase
36
4 to 36 U/L
Gamma-glutamyl transpeptidase
18
Male and female age 45 years and older: 8 to 38 units/L (8 to 38 international units/L)
Female younger than age 45 years: 5 to 27 units/L (5 to 27 international units/L)
Albumin
4.2
3.5 to 5 g/dL
Prothrombin time
11.9
11.0 to 12.5 seconds
Flow Sheet
Initial Vital Signs:
T 97.8 ⁰F (36.5 ⁰C)
HR 74 beats/min
RR 16 breaths/min
BP 128/66 mm Hg
Orders
1105
Isoniazid 300 mg PO daily
Rifampin 600 mg PO daily
Pyrazinamide 1500 mg PO daily
Ethambutol 1200 mg PO daily
Choose the most likely options for the information missing from the statement(s) by selecting from the lists of options provided.
That’s right!
Rationale:
Hepatotoxicity is a risk with antitubercular medications. Regular alcohol consumption can cause liver inflammation. Patients who consume alcohol while taking antitubercular medications are more likely to develop hepatotoxicity. Citrus foods have no effect on antitubercular medications. Rifampin causes reddish orange secretions (including tears) and excretions; however, this side effect is not harmful to the patient. Because alcohol consumption increases the risk of hepatotoxicity with all antitubercular medications, it would not necessitate a medication change.
Anti-infectives – The patient is a 20-year-old man who presents to the clinic today for a follow-up with the pulmonologist after being diagnosed with tuberculosis (TB) of the lungs as a result of infection with Mycobacterium tuberculosis 3 weeks ago
Leave a Reply